CAY-10573 is primarily utilized in research settings as a potent and selective inhibitor of the enzyme soluble epoxide hydrolase (sEH). This enzyme plays a significant role in the metabolism of epoxy fatty acids, which are involved in various physiological processes, including inflammation, pain, and cardiovascular regulation. By inhibiting sEH, CAY-10573 helps in stabilizing these epoxy fatty acids, thereby potentially reducing inflammation and pain. Researchers use this compound to study the effects of sEH inhibition in models of inflammatory diseases, hypertension, and neuropathic pain. Its application extends to exploring therapeutic strategies for conditions such as diabetes, atherosclerosis, and chronic pain disorders. Additionally, CAY-10573 serves as a valuable tool in pharmacological studies aimed at understanding the broader biological roles of epoxy fatty acids and their metabolic pathways.